# Safety and Immunogenicity Study of Ad26-ENVA and Ad35-ENV HIV Vaccines in Healthy HIV-uninfected Adults

> **NCT01215149** · PHASE1 · COMPLETED · sponsor: **International AIDS Vaccine Initiative** · enrollment: 218 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** Ad35-ENV vaccine
- **BIOLOGICAL:** Ad26.ENVA.01 vaccine
- **BIOLOGICAL:** Placebo Control

## Key facts

- **NCT ID:** NCT01215149
- **Lead sponsor:** International AIDS Vaccine Initiative
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 218 (ACTUAL)
- **Last updated:** 2012-12-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01215149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01215149, "Safety and Immunogenicity Study of Ad26-ENVA and Ad35-ENV HIV Vaccines in Healthy HIV-uninfected Adults". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01215149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*